<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="6lu7) of COVID-19. Using these molecular models, we performed virtual" exact="screening" post="with our anti-viral, inti-infectious, and anti-protease compounds, which are"/>
 <result pre="inti-infectious, and anti-protease compounds, which are attractive therapeutics to prevent" exact="infection" post="of the COVID-19. We found that top screened compound"/>
 <result pre="might use to find out specific anti-COVID-19 drugs to control" exact="infection" post="[11]. It was proved that the availability of FDA-approved"/>
 <result pre="FDA-approved anti-RNA-dependent RNA Polymerase (anti-RdRp) drugs could help in the" exact="treatment" post="of patients and reduce the chances of the danger"/>
 <result pre="and reduce the chances of the danger of the viral" exact="infection" post="caused by SARS CoV2. These drugs can tightly bind"/>
 <result pre="using the receptor grid generation module of Maestro. 2.4. Virtual" exact="screening" post="and molecular docking Virtual screening of prepared library was"/>
 <result pre="module of Maestro. 2.4. Virtual screening and molecular docking Virtual" exact="screening" post="of prepared library was operated by using virtual screening"/>
 <result pre="Virtual screening of prepared library was operated by using virtual" exact="screening" post="workflow (VSW) of GLIDE (maestro 12.0, SchrÃ¶dinger, LLC, NY,"/>
 <result pre="docking precision: (1). HTVS (High Throughput Virtual Screening) for fast" exact="screening" post="of huge number ligandâ€™s docking, (2) standard-precision (SP) for"/>
 <result pre="screening of huge number ligandâ€™s docking, (2) standard-precision (SP) for" exact="screening" post="and docking of ligands of unknown quality in large"/>
 <result pre="target proteins and may play a highly influencing against SARS-CoV-2" exact="infection" post="3.3. Estimation of binding-free energy MM/GBSA calculation was performed"/>
 <result pre="proteins showed the binding-free energy values. Compounds selected in virtual" exact="screening" post="has been found to show the good result of"/>
 <result pre="NSP10/NSP16 methyltransferase, which play a crucial role in inhibits the" exact="infection" post="of the virus of COVID 19 [10,11]. It has"/>
 <result pre="silico study may be an excellent agent to combat SARS-CoV-2" exact="infection" post="either alone or in combination. However, it warrants further"/>
 <result pre="of the SARS-CoV-2 (2019-nCoV) 3C-like protease (3CL pro) structure: virtual" exact="screening" post="reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Res."/>
 <result pre="responses to single-stranded RNA bearing 5'-phosphates. Science. 2006;314(5801):997â€&quot;1001.17038589 15KandeelM, Al-NazawiMVirtual" exact="screening" post="and repurposing of FDA approved drugs against COVID-19 main"/>
 <result pre="less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2" exact="infection" post="inÂ vitro. Cell Discov. 2020;6(1):1â€&quot;4.31934347 20PushpendraS, KushwahaPP, ShashankKNovel potent"/>
</results>
